2017 Advances in Cancer Immunotherapy - Los Angeles Recorded Webinar 2

Program Summary
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) webinar recording for the 2017 Los Angeles event is provided here. The purpose of this webinar series is to help healthcare providers stay informed about cancer immunotherapy. 

 

Webinar Faculty

Kim A. Margolin, MD - City of Hope

Teresa Kim, RN, BSN - City of Hope

 

Webinar Date

September 25, 2017

 

View Recorded Webinar

 

 Click here to access the recorded webinar.

2017 Advances in Cancer Immunotherapy - Los Angeles Recorded Webinar 2

Program Summary
From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) webinar recording for the 2017 Los Angeles event is provided here. 

 

Join Kim A. Margolin, MD,  and Teresa Kim, RN, BSN, from City of Hope as they discuss a nurse's role in cancer immunotherapy treatment and adverse events related to cancer immunotherapy.


Questions addressed in this webinar include:

  1. What side effects of immunotherapy require immediate attention?
  2. What are other medications being investigated to mitigate side effects of immunotherapy other then prednisone and mycophenolate?
  3. What roles can a RN play in advancing and promoting use of IO?
  4. It appears the side effects of immunotherapy are downplayed a bit by oncologists. Can you comment on this (i.e. what is "manageable" to the oncologist vs. what is "manageable" to the patient)?
  5. Do you have a panel of blood work that you run routinely on patients who are on treatment?
  6. Do you treat endocrine numbers or watch?
  7. What is a therapeutic does of steroids?
Speaker Information
Teresa Kim, RN, BSN  [ view bio ]
Kim A. Margolin, MD  [ view bio ]
Individual topic purchase: Selected